Washington paid billions for health coverage people never authorized. CMS has canceled roughly 315,000 enrollments covering more than 760,000 people and says $2.2 billion in subsidies will be returned to taxpayers. Sixty-six insurance agents and brokers have lost their exchange agreements, with hundreds more facing termination notices. The cleanup follows years of warnings and nearly 300,000 complaints about unauthorized enrollments and plan switches in 2025. Recovering the money is a start. Explaining how the abuse persisted should come next.

Ethiopia’s fragile peace is breaking apart. Seven armed groups have formed an alliance to oust Prime Minister Abiy Ahmed, while renewed fighting in Tigray threatens to unravel the settlement that ended a war estimated to have killed 600,000 people. Washington signed a defense agreement with Ethiopia in August. Now its new partner faces another internal conflict near the Red Sea, where shipping lanes and neighboring states are already under strain. A renewed Ethiopian war would deepen the instability around one of the world’s most important trade routes.

A visa program sold as a way to recruit exceptional talent has become a fight over replacing American workers with cheaper labor. Research cited here finds H-1B workers earn less than comparable Americans, while major visa sponsors have also cut domestic jobs. Trump has ordered agencies to consider employers’ layoffs when reviewing applications, and Vance calls the program broken. The larger reform still runs through Congress, where one proposal would double the basic annual visa cap.

Florida is suing Pfizer and its CEO over what it alleges were deceptive vaccine safety claims, misleading promises about transmission and unfair business practices. The state is using consumer-protection law, rather than an individual vaccine-injury claim, in an effort to get around broad federal liability protections. Pfizer rejects the allegations and stands behind its vaccine’s safety and effectiveness. No court has decided the case. The fight will test whether pandemic-era marketing can be challenged through state consumer law.